Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last €38.47 EUR
Change Today -0.015 / -0.04%
Volume 545.6K
GRF On Other Exchanges
Symbol
Exchange
OTC US
OTC US
NASDAQ GS
OTC US
Mexico
Continuous
Continuous
Frankfurt
Frankfurt
As of 11:38 AM 07/29/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Shinji Wada

Corporate Vice President, Chairman of Plasma Centers-Grifols Inc., President of Plasma Operations of Grifols Shared Services North America, Inc. and Director of Plasma Centers-Grifols Inc., Grifols, S.A.
AgeTotal Calculated CompensationThis person is connected to 15 board members in 1 different organizations across 1 different industries.

See Board Relationships
----

Background*

Mr. Shinji Wada serves as the Chairman and President of Plasma Operations of Grifols Shared Services North America, Inc. at Grifols, S.A. Mr. Wada has been the Chief Executive Officer of Biomat USA, Inc. since 2005. He started his career in the plasma industry in 1981 working for a Japanese plasma fractionation company, the Green Cross Corporation, parent company of Alpha Therapeutic in Los Angeles. He assumed various positions at Alpha Therapeutic, including M&A, International ...

Read Full Background

Corporate Headquarters*

Avinguda de la Generalitat, 152-158
Barcelona, Catalonia 08174

Spain

Phone: 34 935 71 22 00
Fax: 34 935 71 02 67

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

There is no Education data available.

Other Affiliations*

There is no Company Affiliations data available.

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GRF:SM €38.47 EUR -0.015

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Rajiv Kanishka Liyanaarchchie De Silva Chief Executive Officer, President and Director
Endo International plc
$1.1M
Norman D. Schwartz Chairman, Chief Executive Officer and President
Bio-Rad Laboratories, Inc.
$843.1K
Kåre Schultz Chief Executive Officer and President
H. Lundbeck A/S
--
Jean-Christophe Tellier Chief Executive Officer and Executive Director
UCB S.A.
--
F. Michael Ball Chief Executive Officer, Director and Member of Science & Technology Committee
Hospira Inc.
$1.1M
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GRIFOLS SA, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.